We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current IGMS market cap is 566.11M. The company's latest EPS is USD -4.1917 and P/E is -2.29.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 331k | 372k | 522k | 448k | 509k |
| Operating Income | -60.51M | -56.26M | -63.37M | -68.21M | -66.76M |
| Net Income | -58.04M | -52.58M | -59.31M | -64.42M | -61.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 1.07M | 2.13M |
| Operating Income | -44.5M | -83.28M | -165.32M | -227.96M | -263.46M |
| Net Income | -43.13M | -81.36M | -165.16M | -221.1M | -246.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 540.94M | 513.5M | 462.74M | 480.66M | 474.35M |
| Total Liabilities | 212.76M | 226.24M | 223.31M | 222.05M | 220.49M |
| Total Equity | 328.18M | 287.26M | 239.43M | 258.61M | 253.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 261.35M | 408.63M | 298.13M | 513.5M | 423.41M |
| Total Liabilities | 21.12M | 26.82M | 53.22M | 226.24M | 220.18M |
| Total Equity | 240.23M | 381.82M | 244.91M | 287.26M | 203.23M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 32.01M | -5.85M | -51M | -104.1M | -144.22M |
| Investing | -206.83M | -225.64M | 69.82M | 63.5M | 83.05M |
| Financing | 218.9M | 219.38M | 75k | 70.03M | 114.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.12M | -67.3M | -124.34M | -5.85M | -192.23M |
| Investing | -203.24M | 57.71M | 14.82M | -225.64M | 68.36M |
| Financing | 282.26M | 214.78M | 2.48M | 219.38M | 115.07M |
| Market Cap | 566.11M |
| Price to Earnings Ratio | -2.29 |
| Price to Sales Ratio | 265.19 |
| Price to Cash Ratio | 5.02 |
| Price to Book Ratio | 2.78 |
| Dividend Yield | - |
| Shares Outstanding | 58.79M |
| Average Volume (1 week) | 541.88k |
| Average Volume (1 Month) | 288.73k |
| 52 Week Change | -11.08% |
| 52 Week High | 17.70 |
| 52 Week Low | 3.81 |
| Spread (Intraday) | 4.25 (38.25%) |
| Company Name | IGM Biosciences Inc |
| Address |
corporation trust center dover, delaware 19901 |
| Website | https://www.igmbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
